Brent Pfeiffenberger, President and CEO at Century Therapeutics, Inc. (IPSC), sold 488 shares at $0.50 ($244) on 2025-09-08, disclosed to the SEC on 2025-09-10.
Open-market sale of $244 IPSC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IPSC | SELL | 2025-11-19 | $15K | — | Filing → |
| IPSC | SELL | 2025-06-11 | $295 | — | Filing → |
| IPSC | SELL | 2025-05-20 | $16K | — | Filing → |